Current State of Wheeler-Lea Act Essay Example | Topics and Well Written Essays - 750 words

Current State of Wheeler-Lea Act - Essay Example Still there were a few weaknesses, which were revised by Wheeler Lea act. Congress passed The Wheeler-Lea Act in 1938, a United States government law, which changed the Federal Trade Commission Act. It gave the FTC the extra obligation of policing beguiling acts or practices in trade. In so doing, the FTC attempts to secure the general population against bogus or deluding promoting and the deception of items (Larabee, Robert). So the Federal Trade Commission Act, as altered by the Wheeler-Lea Act, gives new arrangements: The Wheeler-Lea Act has not allowed the FTC to control the publicizing of self-prescription medications. So there has not been as much improvement in patent medication promoting as wished. Professionally prescribed medications are policed by the FDA under the Kefauver-Harris Amendments of 1962. Also, promoting of confined clinical gadgets is controlled by the FDA under the Medical Device Amendments of 1976. Most as of late, Congress passed an expansive change of the FD&C Act in the Food and Drug Modernization Act (FDAMA), which incorporates arrangements to manage publicizing of unapproved employments of endorsed medications and gadgets, and control wellbeing claims for nourishments. There is necessity of forbiddance of out of line techniques for rivalry and publicizing, so as to secure purchasers just as rivalry. Numerous Acts has been passed by U.S government. Wheeler lea Act was a major advance toward this path. It controlled promoting, marking techniques and recognizable proof, quality, and fill-of-compartment for nourishments and medications. References Larabee, Robert. The Federal Trade Commission: A Guide to Sources (Research and Information Guides in Business, Industry, and Economic Institutions), Routledge; 1 version, November 8, 2000. pp-345 U. S. Food and Drug Administration, Order of Drug Regulation in the United States. Last Updated May 10, 2007, Retrieved May 13, 2007. < http://www.fda.gov/cder/about/history/time1.htm